|
Novo Nordisk Pharmaceuticals, Inc. in Princeton, N.J. is a United
States affiliate of Novo Nordisk A/S, a healthcare company and a world
leader in diabetes care.
Novo Nordisk works with healthcare providers,
research organizations, and patient associations to enhance knowledge
about diabetes and the best therapies available. Novo Nordisk uses
recombinant technology to make a comprehensive line of human insulin
and insulin analog products and an oral antidiabetic agent. Novo
Nordisk designed and developed the world’s first insulin pen device and
today is a leader in the production of innovative insulin delivery
systems. To learn more, please visit a Novo Nordisk Pharmaceutical
Sales Representative at the Novo Nordisk booth in the Health Fair.
|